Innate Pharma SA Auditors Remuneration
Innate Pharma SA (IPHYF) reported Auditors Remuneration of EUR 1.29 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:AuditorsRemuneration · last filed 2026-04-01
| Period end | Auditors Remuneration 12 month |
|---|---|
| 2025-12-31 | 1.29M EUR 20-F · filed 2026-04-01 |
| 2024-12-31 | 1.31M EUR 20-F · filed 2026-04-01 |
| 2023-12-31 | 938.00K EUR 20-F · filed 2026-04-01 |
| 2022-12-31 | 1.10M EUR 20-F · filed 2025-04-30 |
| 2021-12-31 | 780.00K EUR 20-F · filed 2024-04-04 |
| 2020-12-31 | 799.00K EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 1.19M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 605.00K EUR 20-F · filed 2021-04-27 |